Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.02540-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Sadanand Dangari Akshay und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science & Technology, Gujarat Biotechnology Research Centre, Government of Gujarat, Gandhinagar, Gujarat, India. Hauptthemen laut MEDLINE: Salmonella typhi, Typhoid Fever, Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antimicrobial resistance (AMR) in Salmonella Typhi ( S . Typhi) is a serious health issue that can complicate typhoid fever treatment and increase fatality rates. The National Centre for Disease Control, Government of India, established a National Antimicrobial Surveillance Network to detect AMR in high-priority infections, including S . Typhi throughout geographical areas of India, and understand AMR dissemination and possible treatment options. The Gujarat State Biotechnology Mission, Government of Gujarat, India, has funded the “Network Program on Antimicrobial Resistance, Superbugs, and One Health” to track antibiotic resistance patterns in the Gujarat region. Given the enormity of the AMR problem in S . Typhi, in Gujarat, this study evaluated the antibiotic resistance patterns of S . Typhi isolates from the Ahmedabad and Vadodara regions of Gujarat, India, were used to determine the mechanism underlying antibiotic resistance and developed combination treatments to combat the extensive drug-resistant isolates. We collected 122 Salmonella isolates periodically (2022–2023) in the Ahmedabad and Vadodara regions of Gujarat, India. The antibiotic susceptibility for 122 S . Typhi isolates was prepared using the disc diffusion method and VITEK II compact system. Whole-genome sequencing and in-silico analysis were performed to identify potential antibiotic resistance genes (ARGs); in addition, combination antibiotic therapies were investigated, and resistance patterns were predicted for key antibiotics used in the treatment of typhoid fever. The study discovered notable levels of antibiotic resistance, specifically to cefuroxime (97.54%), doxycycline (97.54%), ceftriaxone (95.90%), cotrimoxazole (95.90%), ampicillin/sulbactam (95.90%), cefotaxime (94.26%), and ciprofloxacin (94.26%). Genetic analysis revealed the presence of aph(3'')-Ib (40.16%), aph(6)-Id (95.08%), bla CTX-M (89.39%), dfrA14 (68.85%), plasmid-mediated quinolone resistance (PMQR), and the qnrS1 gene (94.26%). IncFIB(K) and IncFIB(pHCM2) were detected in 96.71% of S . Typhi isolates. Point mutations in the QRDR region of gyrA identified three distinct modifications: Ser83Phen (91.80%), Ser83Leu (1.64%), and Ser83Tyr (0.82%). Three genes exhibited point mutations: gyrB (100%), Ile253Val, and parC (6.56%) multiple mutations, and the efflux gene mdtK (100%) Thr224Lys. By evaluating phenotype and genotype, the tests showed an average concordance of 91.69% and a discordance of 8.31%. The study revealed that 97.54% of isolates belonged to the H58 haplotype lineage II (ST1: 4.3.1.2), which is associated with high resistance to cephalosporins and fluoroquinolones in Southeast Asia. The combination therapy of β -lactam/ β -lactamase inhibitors (BL/BLI) demonstrated good outcomes, with low MICs (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science & Technology, Gujarat Biotechnology Research Centre, Government of Gujarat, Gandhinagar, Gujarat, India.
- Department of Microbiology and Biotechnology Centre, Faculty of Science, The Maharaja Sayajirao University of Baroda, , Vadodara, Gujarat, India.
- B.J. Medical College, New Civil Hospital, Ahmedabad, Gujarat, India.
- Commissionerate of Health, Department of Health and Family Welfare, Government of Gujarat, Gandhinagar, Gujarat, India.
- Toprani Advanced Lab Systems, Vadodara, Gujarat, India.
ORCID-Profile: Sadanand Dangari Akshay, Devarshi Gajjar, Chaitanya Joshi
Zitieren
APA
Akshay, S. D., Upadhyaya, H., Shukla, N., Bhattacharjee, R., Das, S., Vyas, U., Chavda, P., Patel, N., Jamkhandi, D., Sabara, P., Khandelwal, N., Soni, S., Upadhyaya, K., Katira, J., Maheshwari, G., Joshi, M., Gajjar, D., & Joshi, C. (2025). Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02540-24
Vancouver
Akshay SD, Upadhyaya H, Shukla N, Bhattacharjee R, Das S, Vyas U, et al. Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02540-24
BibTeX
@article{Akshay2025,
author = {Akshay, Sadanand Dangari and Upadhyaya, Heli and Shukla, Nitin and Bhattacharjee, Rohit and Das, Sunilkumar and Vyas, Urmi and Chavda, Priyank and Patel, Nimesh and Jamkhandi, Dixsha and Sabara, Pritesh and Khandelwal, Neeta and Soni, Sumeeta and Upadhyaya, Kamlesh and Katira, Jayesh and Maheshwari, Geeti and Joshi, Madhvi and Gajjar, Devarshi and Joshi, Chaitanya},
title = {Comprehensive analysis of extensive drug-resistant Salmonella Typhi in Gujarat region, India: genomic findings and prospective alternative therapy},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.02540-24}
}
EUVIMED